Introduction

!
Buruli ulcer (BU) is a skin disease caused by Mycobacterium ulcerans. It usually begins as a painless nodule or papule and may progress to a massive skin ulceration. If untreated, BU may lead to extensive soft tissue destruction that may extend to the deep fascia and sometimes to the bones. BU was recently recognized by the World Health Organization (WHO) as an important emerging disease [1] . The disease has been reported in many countries, mostly tropical, in Africa, North America (Mexico), South America, Southeast Asia, and Oceania. Recent reports have suggested increased incidences of BU in, for example, some areas of Bénin [2] , Australia [3] , and Ivory Coast [4] . Early, limited M. ulcerans infection can be safely and effectively managed by antimycobacterial treatment alone, without surgical debridement. The drug regimen proposed by WHO, consisting of 8 weeks of streptomycin and rifampicin, is effective for early lesions [5] [6] [7] . Surgery seems, however, necessary for some severe forms of the disease (large ulcerated forms, disseminated forms, and osteomyelitis) [8] . This surgical treatment can only be used in a few medical centers with proper and adequate equipment and is neither affordable nor accessible to an important part of the population [9] . Traditional treatment remains the first option for patients with generally low resources [9, 10] . Two previous studies performed in Bénin have described this kind of treatment; notably its cultural context and different forms. We recently observed that most components in this treatment belong to the vegetal kingdom [11] . However, in vitro evaluation of the activities of the natural products used is not documented enough. To our knowledge, only one previous study performed in the Ivory Coast evaluated the in vitro antimycobacterial activity of total aqueous extracts of Sacoglottis gabonensis (Humiriaceae) and Okoubaka aubrevillei (Octoknemataceae) versus seven strains of M. ulcerans from different geographical origins [12] . The purpose of this review is to inventory in vitro tests that can be used to screen natural products Abstract ! Buruli ulcer (BU), caused by Mycobacterium ulcerans, has recently been recognized by the World Health Organization (WHO) as an important emerging disease. It is largely a problem of the poor in remote rural areas and has emerged as an important cause of human suffering. While antimycobacterial therapy is often effective for the earliest nodular or ulcerative lesions, for advanced ulcerated lesions, surgery is sometimes necessary. Antimycobacterial drugs may also prevent relapses or disseminated infections. Efficient alternatives different from surgery are presently explored because this treatment deals with huge restrictive factors such as the necessity of prolonged hospitalization, its high cost, and the scars after surgery. Traditional treatment remains the first option for poor populations of remote areas who may have problems of accessibility to synthetic products because of their high cost. The search for efficient natural products active on M. ulcerans should then be encouraged because they are part of the natural heritage of these populations; they are affordable financially and can be used at the earliest stage. This review provides a number of tests that will help to evaluate the antimycobacterial activity of natural products against M. ulcerans, which are adapted to its slow growing rate, and lists active extracts published up to now in Medline.
for their antimycobacterial activity against M. ulcerans and present our first results. We focused our literature search on publications on Medline PubMed (NCBI) database dealing with the evaluation of activities of natural products against M. ulcerans and limited it to papers published in English or in French. Key words used were "natural products", "antimycobacterial screening", "Buruli ulcer", "Mycobacterium ulcerans", "drugs susceptibility test", "mycobacteria", or/and "plant". All retrieved titles and abstracts were scrutinized for relevant studies that are discussed here. We only found one publication [12] dealing with the evaluation of the activity of natural products against M. ulcerans. Natural antimycobacterial products may be of great importance in the early treatment of BU, preventing the spread of the disease at an affordable cost for the local population. Antimicrobial activity of natural products and pure compounds can be detected by observing the growth response of various microorganisms that are placed in contact with them. Several methods for detecting activity are available, but since they are not equally sensitive or not based upon the same principle, results will be profoundly influenced by the method [13] . The methods used to test antibacterial activity are classified into three main groups, i.e., diffusion, dilution, and radiorespirometry method [14] . These methods are discussed in this review. As M. ulcerans has a slow growing rate and a tendency to clump in liquid medium, these general methods must be adapted to give sensitive and reliable results in an acceptable period of time. In our laboratory, we adapted the proportion method on Löwen-stein Jensen (LJ) medium, using Middlebrook 7H11 agar and Resazurin Microtiter Assay (REMA), to investigate the antimycobacterial activity against M. ulcerans of 44 plants (see l " Table 1 ) employed in traditional medicine in Bénin to treat BU.
Compound Handling and Storage
!
The most frequently used solvents to prepare test products solutions include dimethyl sulfoxide (DMSO), methanol, and ethanol. The latter two, however, have the disadvantage of rapid evaporation whereby the stated concentration of stock solutions cannot be maintained. They also have an inhibitory effect on the growth of mycobacteria. Solutions in 100 % DMSO have become the standard. Added advantages of stock solutions in 100% DMSO are: (1) elimination of microbial contamination, thereby reducing the need for sterilization by autoclaving which can affect the quality of the test product, and (2) good compatibility with test automation and integrated screening platforms, assuring, for example, good solubility during the serial dilution procedures [13] . It is important to note that DMSO is potentially toxic for cells and many microorganisms including M. ulcerans. Then, in order to avoid later interference in the biological test systems, the in-test concentration of DMSO should not exceed 0.625 %. In practical terms, this entails the need for inclusion of an intermediate dilution step in water. Because of the variability of individual compounds, there are no general storage conditions that guarantee sample integrity [15] . A practical recommendation for storage of natural products is either without solvent for long-term storage or in 100 % DMSO at −20°C with minimal exposure to freeze-thaw cycles and humidity.
Growth medium
LJ is a conventional growth culture medium for M. ulcerans. Middlebrook 7H11 agar, Middlebrook 7H9, and Middlebrook 7H12 liquid media are also convenient for the tests. M. ulcerans optimally grows between 30 and 33°C. The incubation period depends on the culture medium used. Tubes are read within 2 to 3 weeks (with Middlebrook 7H12), after 28 and 42 days of incubation (with Middlebrook 7H11 agar), or 72 to 81 days (with LJ), and plates are read after 15 days (with Middlebrook 7H9).
Inoculum
The standardization of the bacterial cell number used for susceptibility testing is of critical importance for obtaining accurate and reproducible results. Inoculum concentration can have a profound influence on the antimycobacterial potency of a natural product, endorsing the need for standardization of inoculates [16] . Fresh colonies of M. ulcerans are collected from the LJ medium and suspended in distilled water; the turbidity of the resulting suspensions is then adjusted with distilled water to match that of a standard 1 mg/mL suspension of M. bovis BCG (containing approximately 10 8 CFU per mL), after which the suspensions are further diluted to 10 −1 and 10 −2 mg/mL. The inocula are 0.1 mL of diluted solutions [17] .
Antimycobacterial Assays
!
Agar diffusion
The agar diffusion assays were first developed for bacteria [18] . Agar diffusion techniques have been widely used to assay plant extracts for antimicrobial activity but have limitations. Disk methods consist of the placing of filter paper disks containing test compounds, at a known concentration, on agar plate surfaces previously inoculated with the bacteria. Plant extracts diffuse into the agar and inhibit growth of the bacteria. After incubation, the diameter of the clear zone (growth inhibition) is measured at the end of the incubation period. In order to enhance the detection limit, the inoculated system is kept in an incubator at 30-33°C during 42 days concerning Mycobacterium ulcerans.
The common disc or well-diffusion assays employed in many antimicrobial assays of natural products are not quantitative when used to evaluate new natural products, but are merely an indication that there is growth inhibition at some unknown concentration along the concentration gradient [19] . However, the agar disk diffusion technique can only be used for drug susceptibility testing of pure substances because when it is applied to mixtures, results may be unreliable [20] . Recently, a M. marinum inhibition zone assay was developed as a model to evaluate antitubercular or antimycobacterial activity of natural products from marine organism extracts [21] . The major disadvantage of using diffusion assays to evaluate activity of natural products against M. ulcerans is that mycobacteria, having a very lipid-rich, hydrophobic cell wall, are often more susceptible to less-polar compounds [22] . Nonpolar compounds will diffuse more slowly than polar compounds in the agar medium and, thus, give a weaker activity. So the diffusion method is not appropriate for testing nonpolar samples or samples that do not easily diffuse into agar. In general, the relative antimicrobial potency of different samples may not always be compared, mainly because of differences in physical properties, such as solubility, volatility, and diffusion characteristics in agar. Further-more, agar-diffusion methods are difficult to run on a high-capacity screening.
Radiorespirometry method
The growth or inhibition of M. ulcerans can be determined in a liquid Middlebrook 7H12 medium within 2 to 3 weeks by the extent of oxidation of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] palmitic acid to 14 CO 2 which is measured in the automated radiometric BACTEC 460 instrument [23, 24] . Because of the quantitative nature of the data obtained in this assay, the relative activity of various samples can be compared by testing at only 1 or 2 concentrations and determining a percent inhibition of 14 CO 2 production compared to product-free controls [25] . Alternatively, multiple concentrations can be tested and MIC calculated [26] . Newer non-radiometric clinical automated systems use indicators of oxygen consumption [27] , carbon dioxide production [28] , or head space pressure [29] to determine growth/inhibition. Tests performed in the BACTEC 460 system are costly and not suited for the evaluation of large numbers of compounds. The major disadvantages of these assays are the cost and the isotope disposal in low-income countries.
Dilution methods
Dilution tests can be applied in solid (agar dilution) or liquid (broth dilution) media. Agar dilution and broth dilution are the most commonly used techniques to determine the minimal inhibitory concentration (MIC) of antimicrobial agents, including antibiotics and other substances that kill (bactericidal activity) or inhibit the growth (bacteriostatic activity) of bacteria. The results obtained allow a quantitative estimate of antimicrobial activity. In the dilution methods, test products are mixed with a suitable medium that will be inoculated with the test organism. It can be carried out in liquid (7H9) as well as on solid media (7H11, LJ). On solid media, growth of the microorganism can be measured by counting the number of colonies. In the agar-dilution method, the minimal inhibitory concentration (MIC) is defined as the lowest concentration able to inhibit any visible microbial growth. In liquid or broth-dilution methods, turbidity and redox-indicators are most frequently used. Turbidity can be estimated visually or obtained more accurately by measuring the optical density. However, test products that are not fully soluble may interfere with turbidity readings, emphasizing the need for a negative control or sterility control, i.e., natural products dissolved in blank medium without microorganisms. Measurements can be obtained with a microplate-reader, but visual reading may also be used in cases where spectrophotometry is not available. Another assay exploits the principle that only living cells convert fluorescein-diacetate to fluorescein, producing a yellowish-green fluorescence under UV light [30] . However, it requires a more significant investment in equipment, and validation is not easy. Fluorescent constituents present in crude natural products extracts may also interfere [31] . In general, dilution methods are appropriate for assaying polar and nonpolar products for determination of MIC on M. ulcerans. Agar dilution: Agar dilution involves the incorporation of different concentrations of extract into a nutrient agar medium followed by the application of a standardized inoculum of bacteria to the surface of the agar tube. After incubation, the presence of bacterial colonies on the medium indicates growth of the organism. Testing of known concentrations of extracts, fractions, or compounds in an agar medium allows for the quantitation of activity and the determination of an MIC. M. ulcerans grows well on Middlebrook 7H11 agar supplemented with oleic acid, albumin, dextrose, and catalase, if incubated with CO 2 . The main disadvantage with such assays is the requirement of at least 28 days to visually detect the growth of colonies [17] . Micro broth dilution: The growth of M. ulcerans can be quantitated by measuring turbidity in a liquid medium; the tendency of mycobacteria to clump makes this test difficult. In addition, crude extracts may also impart some turbidity to the medium, making interpretation of results difficult. The use of alamar blue (an oxidation/reduction indicator dye) makes this test rapid and sensitive. Microplate alamar blue assay (MABA) results can be read visually without the use of instrumentation [32] . The reduced form of alamar blue can be quantitated colorimetrically by measuring absorbance at 570 nm or fluorimetrically by exciting at 530 nm and detecting emission at 590 nm [33] . Non-fluorometric readouts can also be performed by using resazurin [34] [35] [36] or tetrazolium dyes [37] [38] [39] . These methods are also performed on M. tuberculosis as well as non-tuberculous mycobacteria (NMT) [40] . The resazurin microtiter assay (REMA) allows for the detection of microbial growth in a small volume of solution in microtiter plates. We can associate the use of a spectrophotometer (Biotrak II) to suppress the possible interference of color of natural products extracts with the resazurin color. Plates are read with a spectrophotometer at 620 nm. The 96-well microplates offer the advantage of using small volumes of reagents. Plates can be read visually without the need of instrumentation. The MIC is defined as the lowest concentration of extract that prevents a color change of resazurin (blue to pink). The plant extracts that could not prevent growth of M. ulcerans up to a concentration of 250 µg/mL are considered inactive. For screening antibacterial activities of natural products, it is essential to use an in vitro antibacterial assay that is simple, rapid, sensitive, and cost-effective. Usually, small quantities of natural products are available for antibacterial screening, and this can be a limiting factor. Dilution method performed on LJ is time consuming, very slow and requires significant quantities of materials. When performed on 7H11, it requires a CO 2 incubator because M. ulcerans is a microaerophilic bacterium. With the BACTEC 460 system, microaerobic conditions (2.5 to 5 % oxygen) are needed to promote the growth of M. ulcerans. Furthermore, the BACTEC 460 system requires significant, heavy equipment and is very expensive. We therefore decided to focus on the REMA test to screen plant extracts for antimycobacterial activity against M. ulcerans. The resazurin assay using a microtiter plate, described here, is modified to determine the MIC values of natural products against M. ulcerans. The results are considered if, and only if, the negative control wells become blue by the addition of resazurin. We used this test to screen the activity of 44 plants used traditionally to treat BU in Bénin [11] . Results are given in l " Table 1 . Out of the 44 plant extracts tested, two plants inhibited the growth of M. ulcerans at concentrations ≤ 250 µg/mL: Holarrhena floribunda (G. Don) T. Durand and Schinz and Jatropha curcas Linn showed inhibitory activity against M. ulcerans at concentrations of 125 and 250 µg/mL, respectively. Control experiments showed that 0.625 % dimethyl sulfoxide (DMSO, solvent used for extract dissolving) or less in each well did not have any inhibitory effect on the growth of M. ulcerans ATCC 19423.
In traditional medicine, practitioners use different plant combinations to treat BU, but in our study plants were investigated individually. This could explain the low number of plants found to be active against M. ulcerans. It is also probable that these plants are used to treat the symptoms of the disease rather than actually to kill the bacteria. Some plant species may not contain compounds which inhibit the growth of or kill M. ulcerans but may have antiinflammatory, analgesic, anesthetic, antiseptic, anti-edema, or healing properties. Further investigations are now required to isolate active compounds and assess their in vitro and in vivo activities against M. ulcerans. The adapted REMA method is simple, sensitive, and rapid and could be a method of choice to successfully assess antibacterial properties of plant extracts against M. ulcerans at a relatively low cost. This is the first application of the REMA to screen plants extracts against M. ulcerans. Additional methods not described in this review are bioautographic methods and a conductimetric assay detecting microbial growth as a change in the electrical conductivity or impedance of the growth medium [14] . But there are no references using these methods for M. ulcerans.
Test Validation
!
Reference compounds
It is evident that each test should contain at least one reference drug to ascertain test performance and proper interpretation of the screening results. Those listed here are commercially available and should be preferred: rifampicin, streptomycin, amikacin, moxifloxacin, and clarithromycin. The activity of these products has already been tested [17, 29] . In addition, each test should be replicated, preferably as independent repeats. A practical solution is to combine negative and positive controls (i.e., a strain susceptible and a strain resistant to the compound) in each assay.
Test organisms
A well-characterized strain, Mycobacterium ulcerans ATCC 19423 has a known drug susceptibility profile. It is used in many drug susceptibility tests. M. ulcerans is a microorganism that can cause severe disease in humans and constitutes a danger for the employees directly exposed. Personnel handling this microorganism must wear protective gloves and, most importantly, should work in biosafety cabinets class II.
Discussion and Conclusion
!
Natural products constitute an important source of new drugs, and antimycobacterial susceptibility testing methods are necessary to evaluate different extracts and find new active compounds. A number of methods are in current use, ranging from the classical disk diffusion and broth dilution assay to the radiorespirometric method (BACTEC 460). There are several factors that may affect the outcome of susceptibility tests. Reproducibility of laboratory results may be considerably influenced by the method used, and the procedures have to be standardized otherwise the results will vary widely under different test conditions [41] . Standard criteria and standardization of methods for evaluation of plant antimicrobial activity are lacking, and results can differ between authors. Sometimes it is difficult to compare results obtained with plant extracts with published results in the literature because several parameters influence the results, such as the choice of plant extracts, the choice of extraction method, and the choice of antimicrobial method [42] . It is also important to take into account that the evaporation of components could affect the antimicrobial activity and to avoid this, the assays should be carried out under sealed conditions to prevent loss by evaporation.
In general, dilution methods are appropriate for assaying polar and nonpolar extracts or compounds to determine MIC values [13] . We showed that REMA is a method of choice to compare MIC values in M. ulcerans. The use of microtiter plates has led to significant reductions in test compound quantities; furthermore, by using the oxidation/reduction indicator dyes, such as resazurin, the growth/inhibition can be read visually; and the reduced form of these dyes can also be quantitated colorimetrically, by measuring absorbance, or fluorimetrically and have high throughput possibilities. REMA is also able to detect partial inhibition, making it ideal for determining the relative activity of fractions using one or two concentrations. This review has highlighted some methods which can be successfully used to investigate antimycobacterial activities of natural products against the microorganism responsible for BU, an important emerging disease. This could stimulate interest in research of active natural products against M. ulcerans. Phytomedicine is the first treatment used by the poor local population, and studies are required to investigate the possible efficacy of some natural products for the treatment of BU when the WHO recommended treatment cannot be applied immediately. Up to now, only one publication deals with the evaluation of the activity of natural products against M. ulcerans. The development of sensitive, rapid, and inexpensive assays allows researchers in low-income countries to become players in the utilization of their natural product resources. We hope that this review will help researchers to develop these tests.
